BioEnvelop signs exclusive agreement to produce edible film for NuitriCorp, division of Jamieson Laboratories

BioEnvelop signs exclusive agreement to produce edible film for NuitriCorp, division of Jamieson Laboratories Company announces announce that it has entered into an exclusive agreement to manufacture nutraceutical film products for NutriCorp International, a wholly owned division of Jamieson Laboratories.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. PacificHealth Laboratories, Inc. Announces 3rd Quarter Results Company reports revenues were $1.67 million compared to $1.89 million in the same period in 2004, with a net loss of ($154,959), or ($0.02) per basic and fully diluted share compared to a net loss of ($303,343), or ($0.03) per basic and fully diluted share for the same period in 2004. PacificHealth Laboratories, Inc. Announces 3rd Quarter Results Company reports revenues were $1.67 million compared to $1.89 million in the same period in 2004, with a net loss of ($154,959), or ($0.02) per basic and fully diluted share compared to a net loss of ($303,343), or ($0.03) per basic and fully diluted share for the same period in 2004. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Imagenetix Licenses Patent Related to Body Fat Control Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. Imagenetix Licenses Patent Related to Body Fat Control Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. Imagenetix Licenses Patent Related to Body Fat Control Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. Imagenetix Licenses Patent Related to Body Fat Control Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. Imagenetix Licenses Patent Related to Body Fat Control Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. Synutra Reports Second Quarter Performance Company reports net income of $1.9 million for the second quarter on sales of $25.8 million as compared to $13 million for the same three months in 2004, earning $.04 per share in the second quarter, versus a loss of $.03 in the prior year's period. Synutra Reports Second Quarter Performance Company reports net income of $1.9 million for the second quarter on sales of $25.8 million as compared to $13 million for the same three months in 2004, earning $.04 per share in the second quarter, versus a loss of $.03 in the prior year's period. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Royal BodyCare Announces Korean Expansion Company announces the formation of a wholly owned subsidiary, RBC Life Sciences Korea Ltd., in Seoul, South Korea with new branch to begin sales of RBC nutritional supplements in January, 2006. Royal BodyCare Announces Korean Expansion Company announces the formation of a wholly owned subsidiary, RBC Life Sciences Korea Ltd., in Seoul, South Korea with new branch to begin sales of RBC nutritional supplements in January, 2006. AMS Health Sciences, Inc. Announces Third Quarter 2005 Financial Results Company reports sales for the first nine months of 2005 totaled $10.4 million compared to $13.3 million for the same period prior year.Net loss for the first nine months of 2005 was $2,621,737, or ($0.36) per common (diluted) share, compared to a net loss of $1,909,963, or ($0.28) per common (diluted) share prior year. AMS Health Sciences, Inc. Announces Third Quarter 2005 Financial Results Company reports sales for the first nine months of 2005 totaled $10.4 million compared to $13.3 million for the same period prior year.Net loss for the first nine months of 2005 was $2,621,737, or ($0.36) per common (diluted) share, compared to a net loss of $1,909,963, or ($0.28) per common (diluted) share prior year. Frutarom Reports Third Quarter Sales Results Company reports sales of US$ 59.4 million, a 15.6% increase compared with the same quarter of 2004, while gross profit for the third quarter of 2005 rose 18.3% to reach US$ 23 million compared with US$ 19.5 million in the same quarter last year. Frutarom Reports Third Quarter Sales Results Company reports sales of US$ 59.4 million, a 15.6% increase compared with the same quarter of 2004, while gross profit for the third quarter of 2005 rose 18.3% to reach US$ 23 million compared with US$ 19.5 million in the same quarter last year. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. Neptune Progresses in its European Market Penetration of Neptune Krill Oil Company announces that Neptune Krill Oil and its Logo and Trademark have been approved and registered by the European Registration Office. Neptune Progresses in its European Market Penetration of Neptune Krill Oil Company announces that Neptune Krill Oil and its Logo and Trademark have been approved and registered by the European Registration Office. Saw Palmetto Berries Co-op Fights Allegations Company President Gregory Zaino notes that "Prices fluctuate with environmental climate, events, labor and crop volume, not by some fictitious cartel..." Saw Palmetto Berries Co-op Fights Allegations Company President Gregory Zaino notes that "Prices fluctuate with environmental climate, events, labor and crop volume, not by some fictitious cartel..." Natural Health Trends Corp. Announces Additional Investment In China Company has invested an additional $10 million cash into its Chinese subsidiary, as it prepares to meet new Chinese requirements to qualify for the capital requirements as set forth in China's Direct Selling Laws, expected to be adopted on December 1, 2005. Natural Health Trends Corp. Announces Additional Investment In China Company has invested an additional $10 million cash into its Chinese subsidiary, as it prepares to meet new Chinese requirements to qualify for the capital requirements as set forth in China's Direct Selling Laws, expected to be adopted on December 1, 2005. CV Technologies Releases Year-End Numbers Company ended the year with net sales of $31.9 million - an increase of 398% over the $6.4 million achieved the previous year. CV Technologies Releases Year-End Numbers Company ended the year with net sales of $31.9 million - an increase of 398% over the $6.4 million achieved the previous year. Cevena Bioproducts Inc. Appoints Richard Smith to Board Company announces the appointment of Richard (Rick) Smith as Chairman of its Board of Directors. Smith currently serves as President and CEO of Dow AgroSciences Canada Inc., a wholly owned subsidiary of the Dow Chemical Company. Cevena Bioproducts Inc. Appoints Richard Smith to Board Company announces the appointment of Richard (Rick) Smith as Chairman of its Board of Directors. Smith currently serves as President and CEO of Dow AgroSciences Canada Inc., a wholly owned subsidiary of the Dow Chemical Company. Cevena Bioproducts Inc. Appoints Richard Smith to Board Company announces the appointment of Richard (Rick) Smith as Chairman of its Board of Directors. Smith currently serves as President and CEO of Dow AgroSciences Canada Inc., a wholly owned subsidiary of the Dow Chemical Company. Cevena Bioproducts Inc. Appoints Richard Smith to Board Company announces the appointment of Richard (Rick) Smith as Chairman of its Board of Directors. Smith currently serves as President and CEO of Dow AgroSciences Canada Inc., a wholly owned subsidiary of the Dow Chemical Company. New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. Oasis LifeSciences Files Intellectual Property Lawsuit Company has filed suit in United States District Court for the District of Colorado against Resource Maxima LLC, Gary Coe, and Sandra Coe for trademark infringement, unfair competition, misappropriation of business value, and patent infringement, and against SOE Trading and Management for patent infringement. Oasis LifeSciences Files Intellectual Property Lawsuit Company has filed suit in United States District Court for the District of Colorado against Resource Maxima LLC, Gary Coe, and Sandra Coe for trademark infringement, unfair competition, misappropriation of business value, and patent infringement, and against SOE Trading and Management for patent infringement. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Nutraceutical Reports Sales and Income Company reports net sales for the fiscal 2005 fourth quarter were $36.8 million compared to $36.1 million for the same quarter prior year, with net income of $3.0 million, or $0.26 diluted earnings per share, compared to $3.3 million, or $0.28 diluted earnings per share prior year. Nutraceutical Reports Sales and Income Company reports net sales for the fiscal 2005 fourth quarter were $36.8 million compared to $36.1 million for the same quarter prior year, with net income of $3.0 million, or $0.26 diluted earnings per share, compared to $3.3 million, or $0.28 diluted earnings per share prior year. Resource Maxima Responds to Allegations Company challenges the allegations made by Oasis. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	MONTREAL, Nov. 24, 2005 (Canada NewsWire via COMTEX) -- BioEnvelop Technologies Corporation (the "Company" or "BioEnvelop") (BIE - TSX Venture Exchange) is pleased to announce that it has entered into an exclusive agreement to manufacture nutraceutical film products for NutriCorp International. The agreement covers the production and sale of all film-based nutraceutical products sold in the Canadian market for the private label manufacturer. The exclusivity is subject to achieving a minimum sales volume of $4.5 million over a three-year period. Based in Windsor, Ontario, NutriCorp International is a wholly owned division of Jamieson Laboratories, one of North America's leading manufacturers and suppliers of natural source minerals, herbal remedies and nutritional food supplements. Jamieson is Canada's largest Nutritional Supplement manufacturer, marketing three brands: Jamieson Natural Sources, Wampole and Quest Vitamins, for a total of 30.1% market share of the branded Vitamin-Mineral Supplement category. The exclusive agreement demonstrates the successful application of BioEnvelop's high-quality film delivery system in the nutraceuticals industry. BioEnvelop's unique technology maximizes the active ingredient capacity required in value-added over-the-counter nutrition products. The alliance brings together one of the edible film industry's leading quality manufacturers with one of North America's leading suppliers of nutraceutical products. BioEnvelop's manufacturing facility was required to meet Jamieson's strict level of manufacturing requirements in order to execute the agreement with NutriCorp. "The nutraceutical films, manufactured by BioEnvelop, allows us to offer a new and convenient delivery system to our customers and consumers. This innovation is aligned with Jamieson/NutriCorp strategic goals in the worldwide nutritional supplement industry," said Vic Neufeld, President and CEO, Jamieson Laboratories Ltd. "We are pleased to be working with a vitamin and nutritional supplement company of such global prominence. This development goes a long way in confirming our emergence as a key supplier to the health and wellness industry," said Nagui Naoum, President and Chief Executive Officer of BioEnvelop Technologies Corporation. ABOUT BIOENVELOP ---------------- Founded in 1998, BioEnvelop Technologies Corporation (www.bioenvelop.com) develops, manufactures and markets Longevita(R) coating solution, a biodegradable and edible protein-based coating treatment that prolongs shelf life and inhibits humidity transfer in fresh and frozen food products, Bari- Kad(TM), a gel or solid film aimed at the agri-food market, and Miracle Glaçage(TM), which addresses the fruit coating and glaze market. BioEnvelop is also developing applications of its biodegradable films for packaging, protecting and transporting food products. BioEnvelop now markets four (4) distinctive product lines: Longevita(R), Bari-Kad(TM), Miracle Glaçage(TM), as well as BioP100(TM) for the packaging industry. BioEnvelop is registered with the U.S. Food & Drug Administration (FDA) under Title 21, Part 207 of the Code of Federal Regulations (CFR), for the manufacturing of commercial drug products. ABOUT NUTRICORP --------------- NutriCorp International is a division of Jamieson Laboratories specializing in private-label packaging and contract manufacturing. NutriCorp has three strategically positioned locations providing fast and efficient distribution worldwide. Within these facilities they offer a complete start-to- finish pharmaceutical protocol operation. NutriCorp's mission is to be a leader in private label packaging and contract manufacturing. Experienced Research & Development staff can formulate specific products unique to their customers. They strive to develop strategic partners that allow for the production of exceptional pharmaceutically pure products and to constantly meet the expectations of their customers FORWARD LOOKING STATEMENTS -------------------------- Certain statements in this news release contain forward looking statements, which by their nature are necessarily subject to risks and uncertainties that could result in important divergences between predicted and actual results. Such statements reflect the Company's current views with respect to future events, and are based on information currently available to the Company and on hypotheses which it considers to be reasonable; however, management warns the reader that hypotheses relative to future events, several of which are beyond the control of management, could prove to be false, given that they are subject to certain risks and uncertainties. Management declares that it has neither the intention nor the duty to provide public updates for each forward looking statement as a result of new information, new events or for any other reason and that such statements are made as of the date of this news release.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software